Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
06 mars 2018 16h05 HE
|
Atara Biotherapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for...
Todos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screening
05 mars 2018 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, March 05, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) (http://www.Todosmedical.com) today announced the initiation of its first blinded clinical trial for TM-B1 – a...
Cidara Announces Appointment of Chrysa Mineo as Independent Director
01 mars 2018 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the...
INmune Bio to Present at Upcoming Conferences
27 févr. 2018 09h30 HE
|
INmune Bio, Inc.
LA JOLLA, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – INmune Bio, Inc., a cancer immunotherapy company focused on developing therapies that harness the patient’s innate immune system...
Webinar to Reveal Data Supporting the Use of MuScreen™ for Preclinical Immunotherapeutic Development
27 févr. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company...
Tempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and Research
22 févr. 2018 10h30 HE
|
Tempus
CHICAGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...
Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics
09 févr. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company...
Mr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial Officer
06 févr. 2018 08h00 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB:TOMDF) (www.todosmedical.com), a clinical-stage in-vitro diagnostics company focused on the development of blood...
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
05 févr. 2018 08h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies,...
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
25 janv. 2018 08h30 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat non-alcoholic steatohepatitis...